A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation (original) (raw)

• Miller JS . The biology of natural killer cells in cancer, infection, and pregnancy. Exp Hematol 2001; 29: 1157–1168.
  Article CAS Google Scholar
• Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S, Vitale M et al. Human natural killer cell receptors and co-receptors. Immunol Rev 2001; 181: 203–214.
  Article CAS Google Scholar
• Farag SS, Fehniger T, Ruggeri L, Velardi A, Caligiuri MA . Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100: 1935–1947.
  Article CAS Google Scholar
• Natarajan K, Dimasi N, Wang J, Mariuzza R, Margulies DH . Structure and function of natural killer cell receptors: Multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002; 20: 853–885.
  Article CAS Google Scholar
• Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL . Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993; 260: 1121–1124.
  Article CAS Google Scholar
• Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-P58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993; 178: 597–604.
  Article CAS Google Scholar
• Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P . The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181: 1133–1144.
  Article CAS Google Scholar
• Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M . A human killer inhibitory receptor specific for HLA-A. J Immunol 1996; 156: 3098–3101.
  PubMed Google Scholar
• Valés-Gomez M, Reyburn HT, Erskine RA, Strominger J . Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA 1998; 95: 14326–14331.
  Article Google Scholar
• Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R et al. Existence of both inhibitory (p58) and activating (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995; 182: 875–884.
  Article CAS Google Scholar
• Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M et al. The human leucocyte antigen (HLA)-C-specific ‘activating’ or ‘inhibitory’ natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996; 183: 645–650.
  Article CAS Google Scholar
• Valés-Gomez M, Reyburn HT, Mandelboim M, Strominger J . Kinetics of interaction of HLA-ligands with natural killer cell inhibitory receptors. Immunity 1998; 9: 337–344.
  Article Google Scholar
• Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002; 99: 8826–8831.
  Article CAS Google Scholar
• Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL . Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296: 1323–1326.
  Article CAS Google Scholar
• Katz G, Gazit R, Arnon TI, Gonen-Gross T, Tarcic G, Markel G et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 2004; 173: 1819–1825.
  Article CAS Google Scholar
• Uhrberg M, Valiante NM, Shum BP . Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753–763.
  Article CAS Google Scholar
• Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT . Population frequencies and putative haplotypes of the killer cell immunoglobuline-like receptor sequences and evidence for recombination. Transplantation 1999; 68: 1784–1789.
  Article CAS Google Scholar
• Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Parham P . Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 2002; 168: 2307–2315.
  Article CAS Google Scholar
• Ljunggren HG, Karre K . In search of the missing self: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237–244.
  Article CAS Google Scholar
• Algarra I, Cabrera T, Garrido F . The HLA crossroad in tumor immunology. Hum Immunol 2000; 61: 65–73.
  Article CAS Google Scholar
• Elkins WL, Pickard A, Pierson GR . Deficient expression of class-I HLA in some cases of acute leukemia. Cancer Immunol Immunother 1984; 18: 91–100.
  Article CAS Google Scholar
• Brouwer RE, van der Heiden P, Schreuder GM, Mulder A, Datema G, Anholts JD et al. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon. Hum Immunol 2002; 63: 200–210.
  Article CAS Google Scholar
• Demanet C, Mulder A, Deneys V, Worsham MJ, Claas FH, Ferrone S . Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? Blood 2004; 103: 3122–3130.
  Article CAS Google Scholar
• Ruggeri L, Capanni M, Martelli MF, Velardi A . Cellular therapy: exploiting NK cell alloreactivity in transplantation. Curr Opin Immunol 2001; 8: 355–359.
  CAS Google Scholar
• Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2101.
  Article CAS Google Scholar
• Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A . The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol 1995; 23: 1667–1675.
  CAS PubMed Google Scholar
• Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814–819.
  Article CAS Google Scholar
• Verheyden S, Bernier M, Demanet C . Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia 2004; 18: 2002–2007.
  Article CAS Google Scholar
• Maxwell LD, Williams F, Gilmore P, Meenagh A, Middleton D . Investigation of killer cell immunoglobulin-like receptor gene diversity: II. KIR2DS4. Hum Immunol 2004; 65: 613–621.
  Article CAS Google Scholar
• Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31: 429–434.
  Article CAS Google Scholar
• Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M . Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004; 173: 4273–4276.
  Article CAS Google Scholar
• Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521–1526.
  Article CAS Google Scholar
• Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002; 100: 3825–3827.
  Article CAS Google Scholar
• Bishara A, De Santis D, Witt CC, Brautbar C, Christiansen FT, Or R et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004; 63: 204–211.
  Article CAS Google Scholar
• Bornhauser M, Schwerdtfeger R, Martin H, Frank KH, Theuser C, Ehninger G . Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 2004; 103: 2860–2862.
  Article Google Scholar
• Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 2001; 166: 2992–3001.
  Article CAS Google Scholar